Skip to main content
AmigoFish

Foundayo GLP-1 Pill: FDA Needs More Data

From On The Pen GLP-1 News · · 20 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Orforglipron (also known as Foundayo) is one of the most promising drugs in the GLP-1 space, notably as only the second oral GLP-1 option for obesity. Unlike injectable treatments, it does not require refrigeration and is easier to scale for widespread use.

Dave highlights the ongoing questions that linger about the drugs approval as it relates to liver safety.

Back to On The Pen GLP-1 News · Report a problem